China Biologic Products Holdings, Inc. — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ee60ee55-8f62-411b-9990-871200a9a5c2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $163.6M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-032518 |
| FY 2018 | $146.2M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-012555 |
| FY 2017 | $135.9M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-011790 |
| FY 2016 | $143.9M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-010658 |
| FY 2015 | $132.6M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-084312 |
| FY 2014 | $111.2M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-013977 |
| FY 2013 | $86.9M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-015131 |
| FY 2012 | $74.5M | 2012-01-01 – 2012-12-31 | evidence 0001062993-13-001166 |
| FY 2011 | $32.2M | 2011-01-01 – 2011-12-31 | evidence 0001204459-12-000493 |
| FY 2010 | $68.6M | 2010-01-01 – 2010-12-31 | evidence 0001204459-12-000493 |
| FY 2009 | $60.5M | 2009-01-01 – 2009-12-31 | evidence 0001204459-12-000493 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
China Biologic Products Holdings, Inc. — all facts · Revenue · Net Income